Page last updated: 2024-09-03

tyrosyl-leucyl-n-methylphenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Chronic Disease

tyrosyl-leucyl-n-methylphenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with Chronic Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Panula, P; Pertovaara, A; Wei, H1

Other Studies

1 other study(ies) available for tyrosyl-leucyl-n-methylphenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Chronic Disease

ArticleYear
Modulation of pain by [1DMe]NPYF, a stable analogue of neuropeptide FF, in neuropathic rats.
    Brain research, 2001, May-11, Volume: 900, Issue:2

    Topics: Animals; Behavior, Animal; Chronic Disease; Electric Stimulation; H-Reflex; Hot Temperature; Hyperalgesia; Injections, Spinal; Nervous System Diseases; Neurons; Nociceptors; Oligopeptides; Pain; Periaqueductal Gray; Rats; Reference Values; Spinal Cord; Touch

2001